{"id":"W3082374255","doi":"10.1111/apt.16060","title":"Long‐term safety of vedolizumab for inflammatory bowel disease","year":2020,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":191,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Bible College","funders":"Takeda Pharmaceutical Company","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Discontinuation; Gastroenterology; Adverse effect; Inflammatory bowel disease; Crohn's disease; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002507542,0.0002506332,0.0005349424,0.0001647588,0.000235909,0.0005257224,0.0002689566,0.0004303618,0.001593858],"category_scores_gemma":[0.002235999,0.00008382377,0.0005240901,0.0001457465,0.0001788933,0.0003942336,0.0001772587,0.001016143,0.0003821634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004544593,"about_ca_system_score_gemma":0.0003294299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002115961,"about_ca_topic_score_gemma":0.0005907994,"domain_scores_codex":[0.9993318,0.0002738428,0.0000818848,0.00005531827,0.0001833435,0.00007383198],"domain_scores_gemma":[0.9979799,0.0006098725,0.00087136,0.00008225709,0.0002370311,0.0002196273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06444588,0.003206348,0.1797492,0.001894559,0.001917472,0.0008589152,0.0002412647,0.002186548,0.06757054,0.0003434993,0.006642067,0.6709437],"study_design_scores_gemma":[0.01673286,0.1904807,0.696133,0.0008391633,0.00325802,0.007602132,0.0002137582,0.00456307,0.03857836,0.0006869045,0.04082705,0.00008503086],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9444582,0.04889695,0.001107139,0.001185988,0.0001026119,0.000126791,0.0006160484,0.00007585366,0.003430407],"genre_scores_gemma":[0.9956542,0.002537663,0.0002960414,0.0003747796,0.00009783556,0.00004933858,0.0005651774,0.000006650508,0.0004182249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002507542,"threshold_uncertainty_score":0.01326126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01966195509693977,"score_gpt":0.292556701332228,"score_spread":0.2728947462352882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}